Lantheus Holdings Inc (FRA:0L8)
€ 88.82 3.24 (3.79%) Market Cap: 6.14 Bil Enterprise Value: 5.91 Bil PE Ratio: 15.32 PB Ratio: 5.43 GF Score: 91/100

Lantheus Holdings Inc at UBS Global Healthcare Conference Transcript

May 21, 2019 / 05:00PM GMT
Release Date Price: €21.5 (-1.29%)
Artan Ferati

Welcome to the 2019 UBS Health Care Conference. I'll be your host for the session. My name is Artan Ferati. With us here today we have Mary Anne Heino from Lantheus Holdings. She is the President and CEO. Immediately after this presentation, the company will be in the Uris breakout room.

Mary Anne Heino
Lantheus Holdings, Inc. - CEO, President & Director

Thank you, and good afternoon, everyone. Next slide, please. Before I begin, I will draw everyone's attention to this slide, which is our cautionary note regarding forward-looking statements for access to all of our filings. You can look at either Lantheus' website or at our filings on SEC.gov. That will alert you to any forward-looking statements that I might make today. Thank you. Next slide, please.

Today, I'm going to focus my comments around what we call our Lantheus story and our story really revolves around these 4 areas: where we see ourselves as a market leader in diagnostic imaging agents; the opportunity that we see in, especially in those areas that we see as growing markets

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot